Reduction of severe exacerbations and hospitalization-derived costs in alpha-1-antitrypsin-deficient patients treated with alpha-1-antitrypsin augmentation therapy
Date issued
2012Journal title
Therapeutic advances in respiratory disease
Type of content
Artigo